Concepedia

Christine A. Shaw

CA

Statistics

Publications

32

Citations

5K

H-Index

23

Active since

1999

Affiliations

Moderna Therapeutics (United States)(Current)

Novartis (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Harvard University

Velocity Clinical Research (United States)

Christine A. Shaw is an author at Moderna Therapeutics (United States) specializing in vaccinology, infectious diseases, and viral vaccines.

Publications per year

1999–2025

32

Publications

32

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist et al. · Nature · 2020 · 1.7K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Nonviral delivery of self-amplifying RNA vaccines

Andrew J. Geall, Ayush Verma, Gillis R. Otten et al. · Proceedings of the National Academy of Sciences · 2012 · 667 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults

Eleanor Wilson, Jaya Goswami, Abdullah H Baqui et al. · New England Journal of Medicine · 2023 · 453 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +17

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Luis A. Brito, Michelle Y. Chan, Christine A. Shaw et al. · Molecular Therapy · 2014 · 333 citations · Full text

Pharmacy, Biotechnology, Immunology +17

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

Kurt A. Swanson, Ethan C. Settembre, Christine A. Shaw et al. · Proceedings of the National Academy of Sciences · 2011 · 286 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–5 of 32